VELOCITY CLINICAL RESEARCH
Velocity Clinical Research, a leading name in the clinical research industry, is headquartered in the United States and operates across multiple regions, including major cities nationwide. Founded in 2018, the company has rapidly established itself as a key player in the realm of clinical trials, focusing on delivering high-quality research services that enhance patient outcomes. Specialising in Phase I-IV clinical trials, Velocity Clinical Research offers a unique blend of expertise and innovation, ensuring efficient study execution and robust data collection. Their commitment to patient-centric research and operational excellence has garnered recognition, positioning them as a trusted partner for pharmaceutical and biotechnology companies. With a strong emphasis on advancing medical science, Velocity Clinical Research continues to make significant strides in the industry, contributing to the development of groundbreaking therapies.
DitchCarbon Score
How does VELOCITY CLINICAL RESEARCH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VELOCITY CLINICAL RESEARCH's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
VELOCITY CLINICAL RESEARCH's reported carbon emissions
Velocity Clinical Research, headquartered in the US, currently does not have available data on carbon emissions or specific climate commitments. Without emissions data, it is unclear what their current carbon footprint is or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented reduction targets or initiatives outlined in their climate strategy. As such, it is difficult to assess their contributions to climate action or any significant achievements in reducing carbon emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VELOCITY CLINICAL RESEARCH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
